March Biosciences and Cancer Focus Fund Announce $4.8 Million Investment to Support a Phase 2 Clinical Trial of Novel CAR-T Therapy for T-Cell Lymphoma by rpadmin | Nov 9, 2023 | March
Cancer Focus Fund invests $4.8M into Houston-based March Biosciences by rpadmin | Nov 9, 2023 | March